Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06379061 · ClinicalTrials.gov registry record
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 650
- Enrollment target
NCT06379061: Completed study, sponsored by Beckman Coulter.
NCT06379061 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 650 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06379061 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 650 participants
- Enrollment target
Study Summary
The purpose of the pivotal study is to collect blood specimens and clinical data from pediatric (\>90 days old) and adult (≥18 years old) patients presenting with signs and symptoms suggestive of acute bacterial or viral infection. These samples will be used to establish the diagnostic performance of MeMed BV™ for differentiating bacterial from viral infection using method comparison and/or method concordance.
Primary Outcome
Collect blood specimens across multiple age ranges presenting symptoms of acute or viral infection
Interventions
- OTHER Adult and Pediatrics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2024-06-12 |
| Est. Completion | 2025-04-30 |
What the finished NCT06379061 record still lists
NCT06379061 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Adult and Pediatrics is the first listed.
NCT06379061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06379061 about?
NCT06379061 is a clinical study titled "Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts". The purpose of the pivotal study is to collect blood specimens and clinical data from pediatric (\>90 days old) and adult (≥18 years old) patients presenting with signs and symptoms suggestive of acute bacterial or viral infection. These samples will be used to establish the diagnostic performance o...
What is the current status of trial NCT06379061?
This trial is currently completed. The enrollment target is 650 participants. The study started on 2024-06-12. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06379061?
The interventions under investigation include: Adult and Pediatrics (OTHER).
Who is sponsoring clinical trial NCT06379061?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI